In Vivo Toxicology Market Projected For Strong Expansion Through 2030: Key Trends And Future Outlook
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
In Vivo Toxicology Market Growth From $6 Billion In 2026 To $7.79 Billion By 2030 At A CAGR Of 6.7%
Significant growth has been observed in the in vivo toxicology market over recent years. It will grow from $5.61 billion in 2025 to $6 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion can be linked to factors such as the scarcity of standardized animal models, dependence on manual laboratory processes, an increase in pharmaceutical research and development endeavors, the rising occurrence of chronic disease investigations, and the adoption of fundamental imaging and analytical instruments.
The in vivo toxicology market is anticipated to show significant expansion in the coming years, with its size projected to reach $7.79 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This growth in the forecast period is primarily attributed to the development of genetically modified organisms for focused research, the integration of automated and high-throughput screening technologies, an increase in contract research organization (CRO) outsourcing for toxicology evaluations, advancements in in vivo imaging and monitoring solutions, and a growing emphasis on alternative testing methods and the reduction of animal testing. Significant trends expected during this period include a rising adoption of rodent and non-human primate models, an increased demand for advanced toxicology assay kits and reagents, the expansion of services for immunotoxicity and genotoxicity testing, the growing implementation of automated liquid handling and imaging systems, and heightened regulatory compliance and ethical standards in animal testing.
Get A Free Sample Report With In-Depth Market Insights:
In Vivo Toxicology Market Growth Factors: What’s Supporting Expansion?
A rising volume of drug discoveries is anticipated to drive expansion in the in vivo toxicology market moving ahead. Drug discovery encompasses the scientific process of identifying and designing novel compounds with potential as treatments or preventative measures for a range of ailments. Advances in biotechnology have greatly accelerated this process by improving comprehension of disease mechanisms and facilitating the development of more specific treatments. In vivo toxicology plays a crucial role in drug discovery, allowing for the assessment of the safety profile, tolerability, and any potential negative effects of compounds under investigation within intact organisms. It assists in pinpointing toxicities that limit dosage and guides decisions on formulation and dosing approaches before clinical trials begin. As an example, in November 2024, the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, reported that more than 12,000 new medicines were undergoing clinical trials in 2023, which was an increase from approximately 9,000 in 2022. Oncology made up 33% of this pipeline, while infectious diseases accounted for 13% and central nervous system diseases for 12%. Consequently, the expanding volume of drug discoveries is stimulating the expansion of the in vivo toxicology market.
In Vivo Toxicology Market Breakdown By Product Type And Application
The in vivo toxicology market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing
3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals
4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications
5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms
Subsegments:
1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents
2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems
In Vivo Toxicology Market Industry Trends: What’s Reshaping Demand?
Leading companies within the in vivo toxicology market are concentrating on developing sophisticated solutions, particularly secure cloud-based real-time data platforms, to enhance study management and accelerate decision-making. These secure platforms allow researchers and clients to access toxicology study data, milestones, planning tools, and essential documents remotely and securely, thereby improving collaboration and transparency. For instance, in March 2023, Charles River Laboratories International Inc., a US-based contract research organization, introduced Apollo, a secure cloud-based platform designed to offer real-time access to toxicology study data. This secure, cloud-based platform is specifically built to support in vivo general toxicology studies, providing instruments for data visualization, planning, and milestone tracking. It facilitates quicker and more informed decisions through immediate access to vital study information. Furthermore, the platform assists in streamlining project planning and budget estimation throughout the entire drug development process. By digitizing toxicology workflows, Apollo significantly boosts precision, efficiency, and collaboration in in vivo research.
In Vivo Toxicology Market Company Landscape And Competitive Strategy
Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.
View The Full In Vivo Toxicology Market Report:
In Vivo Toxicology Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
